|
1
|
Barbera JA, Peinado VI and Santos S:
Pulmonary hypertension in chronic obstructive pulmonary disease.
Eur Respir J. 21:892–905. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dorfmuller P, Perros F, Balabanian K and
Humbert M: Inflammation in pulmonary arterial hypertension. Eur
Respir J. 22:358–363. 2003. View Article : Google Scholar
|
|
3
|
Weitzenblum E, Chaouat A, Canuet M and
Kessler R: Pulmonary hypertension in chronic obstructive pulmonary
disease and interstitial lung diseases. Semin Respir Crit Care Med.
30:458–470. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barbera JA and Blanco I: Pulmonary
hypertension in patients chronic obstructive pulmonary disease
advances in pathophysiology and management. Drugs. 69:1153–1171.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang H, Yang H and Tracey KJ:
Extracellular role of HMGB1 in inflammation and sepsis. J Intern
Med. 255:320–331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grasser M, Lentz A, Lichota J, Merkle T
and Grasser KD: The Arabidopsis genome encodes structurally
and functionally diverse HMGB-type proteins. J Mol Biol.
358:654–664. 2006.
|
|
7
|
Ferhani N, Letuve S, Kozhich A, et al:
Expression of high-mobility group box 1 and of receptor for
advanced glycation end products in chronic obstructive pulmonary
disease. Am J Respir Crit Care Med. 181:917–927. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rabe KF, Hurd S, Anzueto A, et al: Global
strategy for the diagnosis, management and prevention of chronic
obstructive pulmonary disease: GOLD executive summary. Am J Respir
Crit Care Med. 176:532–555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wouters EF, Groenewegen KH, Dentener MA
and Vernooy JH: Systemic inflammation in exacerbation of COPD.
Thorac Soc. 4:626–634. 2007. View Article : Google Scholar
|
|
10
|
Gea J, Barreiro E and Orozco-Levi M:
Systemic inflammation in COPD. Clin Pulm Med. 16:233–242. 2009.
View Article : Google Scholar
|
|
11
|
Yamada S and Maruyama I: HMGB1, a novel
inflammatory cytokine. Clin Chim Acta. 375:36–42. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Štros M, Bačíková A, Polanská E, Štokrová
J and Strauss F: HMGB1 interacts with human to poisomerase alpha
and stimulates its catalytic activity. Nucleic Acids Res.
35:5001–5013. 2007.
|
|
13
|
Ferhani N, Letuve S, Kozhich A, et al:
Expression of high-mobility group box 1 and of receptor for
advanced glycation end products in chronic obstructive pulmonary
disease. Am J Respir and Crit Care Med. 181:917–927. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Penzo M, Molteni R, Suda T, et al:
Inhibitor of NF-kappa B kinases alpha and beta are both essential
for high mobility group box 1-mediated chemotaxis. J Immunol.
184:4497–4509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Palumbo R, Galvez BG, Pusterla T, et al:
Cells migrating to sites of tissue damage in response to the danger
signal HMGB1 require NF-kappa B activation. J Cell Biol. 179:33–40.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qin YH, Dai SM, Tang GS, et al: HMGB1
enhances the proinflammatory activity of lipopolysaccharide by
promoting the phosphorylation of MAPK p38 through receptor for
advanced glycation end products. J Immunol. 183:6244–6250. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kew RR, Penzo M, Habiel DM and Marcu KB:
The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential
to sustain a CXCL12 autocrine loop in cells migrating in response
to HMGB1. J Immunol. 188:2380–2386. 2012.
|
|
18
|
Frenette PS, Mayadas TN, Rayburn H, Hynes
RO and Wagner DD: Susceptibility to infection and altered
hematopoiesis in mice deficient in both P-and E-selectin. Cell.
84:563–574. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Naka Y, Toda K, Kayano K, Oz MC and Pinsky
DJ: Failure to express the P-selectin gene or P-selectin blockade
confers early pulmonary protection after lung ischemia or
transplantation. Proc Natl Acda Sci USA. 94:757–761. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bruck R, Schey R, Aeed H, Hochman A,
Genina O and Pines M: A protective effect of pyrrolidine
dithiocarbamate in a rat model of liver cirrhosis. Liver Int.
24:169–176. 2004. View Article : Google Scholar : PubMed/NCBI
|
